GRTXD · Galera Therapeutics, Inc.
$18.99
At close · Aug 3
Going-concern doubt
— flagged May 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As a result of these conditions, it expects its existing cash and cash equivalents as of March 31, 2026 will not enable the Company to fund its operating expenses and capital expenditure requirements for more than one year after the date these consolidated financial statements are issued, and therefore management has concluded that substantial doubt exists about the Company's ability to continue as a going concern.”View the 10-Q filed May 14, 2026
Market Cap
$3.05B
Shares
160.43M
Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.
Holders: 1
Total Value: $4
Total Shares: 93
Institutional Ownership Trend
19 quarters
Holder Concentration
Across 1 13F filers · Δ vs Jun 30, 2024Top Holder
100.0%
0.0 pts
Top 5
100.0%
0.0 pts
Top 10
100.0%
0.0 pts
HHI
10,000
Highly concentrated0
Quarterly Activity
vs Jun 30, 2024
New
1
Increased
0
Decreased
0
Sold Out
1
Unchanged
0
Holder count:
0
Institutional value:
-99.9%
Shares held:
-99.8%
Top New Positions
vs Jun 30, 2024| Institution | Acquired | Value (USD) | Open |
|---|---|---|---|
| Micro Ascentis Independent Advisors | 0 | $4 |
Top Sold-Out Positions
vs Jun 30, 2024| Institution | Previously Held | Last Value (USD) | Open |
|---|---|---|---|
| Mid XTX Topco Ltd | 261 | $7,129 |
| Holder | Value (USD) | % of 13F | Shares | Type | Filed | Open |
|---|---|---|---|---|---|---|
| Micro Ascentis Independent Advisors | $4 | 100.00% | 93 | Shares | 2026-04-28 |